SCA Chronic Disease Management: When the Curveball Changes Everything

Chronic disease cases in the SCA rarely play out as straightforward management reviews. The RCGP designs them with a curveball: the patient who was stable is now deteriorating, the medication that was working is causing problems, or the routine appointment reveals something that changes the entire plan. This guide covers how to handle the curveball without losing your consultation structure.

10 min read · Reviewed by Dr. Li Low, MRCGP

Key Takeaways

Chronic disease SCA cases almost always contain a curveball. The case notes suggest a routine review, but the consultation reveals something unexpected.
The curveball tests your adaptability. Can you adjust your plan when the clinical picture changes mid-consultation?
The most common mistake is sticking to the original plan. If the patient reveals new information that changes the clinical picture, your management plan must change too.
These cases test shared decision-making heavily. The patient often has strong preferences about their treatment that may conflict with guidelines.

What You Will Learn

Chronic disease SCA cases almost always contain a curveball that changes the plan.
The curveball tests adaptability: can you adjust when the clinical picture shifts?
Shared decision-making is heavily tested in these cases.
The most common mistake is sticking to the original plan when new information emerges.

What Makes Chronic Disease Cases Different in the SCA

The SCA blueprint includes long-term conditions as one of the 12 RCGP clinical experience groups. But the cases the RCGP designs for this group are never simple medication reviews or routine check-ups. They always contain an element that disrupts the expected flow of the consultation.

The case notes might say: "Mrs Khan, 62, type 2 diabetes, annual review." You prepare for a standard diabetic review: check HbA1c, review medication, discuss diet and exercise, foot check, eye screening. But when the consultation starts, Mrs Khan tells you she stopped taking metformin three months ago because of side effects, and she has been relying on a herbal supplement she found online.

That is the curveball. Everything you planned changes. The consultation is no longer a routine review. It is a negotiation about medication adherence, a discussion about alternative treatments, and an exercise in shared decision-making under time pressure.

The RCGP uses curveballs because they test a skill that routine reviews do not: adaptability. Can you recognise when the clinical picture has shifted, abandon your pre-planned approach, and construct a new plan in real time? This is what GPs do every day, and it is what the SCA is designed to assess.

MedTutor has 12 chronic disease curveball cases across cardiovascular, renal, endocrine, neurological, dermatological, and care of the elderly specialties. Each one is designed to present as a routine review that becomes something more complex.

Spotting the Curveball Early

The earlier you spot the curveball, the more time you have to adapt. Look for signals in two places: the case notes during reading time, and the patient's opening statements.

In the reading time: Look for clues that suggest complexity beyond a straightforward review. Multiple medications (polypharmacy risk). Recent blood results included in the notes (something may have changed). A vague reason for attendance ("review" or "follow-up" without specifying what prompted it). Any mention of recent hospital admissions or specialist input (the management landscape may have shifted).

In the first 3 minutes: Listen for statements that do not fit the expected narrative. "Actually, I wanted to talk about something else today." "I've been meaning to mention that I stopped taking..." "My daughter read something about..." "I've been feeling different since..." These are the curveball. Follow them immediately. Do not park them and continue with your planned review structure.

The worst response to a curveball is to ignore it and continue with the plan you prepared during reading time. The examiner watches for this. If the patient says "I stopped my medication" and you continue asking about their foot check, you have missed the consultation.

Practise spotting curveballs with Statin Counselling and QRISK Assessment. The case notes suggest a cardiovascular risk discussion. The curveball is the patient's specific concerns about statin side effects, which changes the consultation from "explain the risk" to "negotiate a treatment plan with a sceptical patient."

Adapting Your Plan Mid-Consultation

When the curveball lands, you need to make a rapid decision: what was my plan, what has changed, and what is the new priority?

This is where the 5-5-2 time management framework earns its value. If you have been disciplined about transitioning to management by minute 6, you have enough time to adapt. If you have spent 8 minutes on a pre-planned review before the curveball emerges, you are in trouble.

The adaptation process:

Acknowledge the new information. "Thank you for telling me about that. That changes what I think we should focus on today." This signals to both the patient and the examiner that you have recognised the shift.

Reprioritise. The original review agenda may still be relevant, but the curveball is now the priority. "I was going to discuss your usual review today, but what you've just told me about stopping the medication is more important. Let's focus on that, and we can cover the rest at your next appointment."

Construct a new plan in real time. This is the hardest part and the part the examiner is most interested in. Can you formulate a management plan for a situation you did not expect? This requires clinical knowledge, but it also requires comfort with uncertainty. You may not have a perfect plan. A safe, sensible plan that you construct collaboratively with the patient is better than a textbook plan that you deliver as a monologue.

Acute Kidney Injury from NSAIDs is an excellent case for practising adaptation. The case notes show a patient with chronic pain who has been taking regular NSAIDs. The curveball is that recent blood results (visible in the notes or revealed during the consultation) show a deterioration in renal function. Your planned pain review becomes an urgent medication safety conversation.

Shared Decision-Making in Chronic Disease

Shared decision-making is tested more heavily in chronic disease cases than in any other case type. The examiner is specifically watching whether you impose a management plan or build one collaboratively.

The reason is simple: chronic disease management is ongoing. The patient will be living with this condition and taking these medications long after the consultation ends. A plan that the patient has helped create is more likely to be followed than a plan that was delivered as an instruction.

What shared decision-making looks like in practice:

Present options, not instructions. "There are a couple of approaches we could take here. I'd like to explain both and then we can decide together which makes most sense for you." Not: "I'm going to start you on metformin."

Acknowledge the patient's expertise in their own life. They know their schedule, their preferences, their concerns about medication, their willingness to change their lifestyle. You know the clinical evidence. The management plan needs to incorporate both.

Accept that the patient may choose something you would not. A patient who declines a statin after you have explained the cardiovascular risk has made an informed decision. Document the discussion. Arrange follow-up. You do not need agreement. You need evidence that you informed, listened, and planned together. See our strong patient agenda guide for more on managing disagreements.

Use open questions to test understanding. "Can you tell me in your own words what we've agreed today?" This checks understanding and demonstrates person-centred care to the examiner.

Medication Conversations: Side Effects, Adherence, and Stopping

Many chronic disease curveballs involve medication. The patient has stopped taking a drug, is experiencing side effects, wants to switch to an alternative, or has read something concerning online.

These conversations require a specific approach:

Do not react negatively to non-adherence. "Why did you stop taking it?" in a disapproving tone shuts the conversation down. "Can you tell me what made you decide to stop?" in a curious tone opens it up. Non-adherence is information, not a failure. The patient's reason for stopping often reveals a solvable problem: side effects, cost, inconvenience, fear, or misunderstanding.

Take side effect concerns seriously. Statin myalgia, metformin GI effects, antihypertensive dizziness. These are real and they affect the patient's quality of life. Dismissing them ("The benefits outweigh the risks") without first acknowledging the experience fails Relating to Others.

Discuss stopping or switching as a legitimate option. If a medication is causing significant side effects, stopping or switching is a valid management decision. Present it as an option alongside dose adjustment, timing changes, or combination therapy. The examiner wants to see that you considered alternatives, not that you insisted on the original prescription.

Practise medication conversations with Polypharmacy in the Elderly: Medication Review, where the curveball is an elderly patient on multiple medications with potential interactions, and the consultation becomes a deprescribing conversation. Perinatal Mental Health: Sertraline in Pregnancy tests medication conversations in a particularly sensitive context: the patient is pregnant and has concerns about the safety of continuing her antidepressant.

Lifestyle Conversations That Don't Sound Like Lectures

Chronic disease management almost always involves a lifestyle component: diet, exercise, alcohol, smoking, weight. The SCA tests whether you can discuss lifestyle changes in a way that is motivating rather than patronising.

The most common mistake is the lifestyle lecture. The trainee delivers a monologue about the importance of diet and exercise, using language that sounds like a public health leaflet. The patient nods politely. The examiner notes that the trainee talked at the patient rather than with them.

A better approach:

Ask before telling. "What do you already know about how diet affects blood sugar?" Start with the patient's existing knowledge rather than assuming ignorance.

Be specific and practical. "Reducing your carbohydrate portions by a quarter and walking for 20 minutes after your evening meal can make a significant difference" is more actionable than "You need to improve your diet and exercise more."

Acknowledge difficulty. "I know this is a lot to take on, especially alongside everything else going on in your life. We don't need to change everything at once. What feels like the most manageable place to start?" This is story-led consulting in action: connecting the management plan to the patient's actual life.

Avoid moral language. "Good" and "bad" foods. "Cheating" on a diet. "Compliance." These words imply judgement and create resistance. Neutral language ("foods that raise blood sugar more quickly" vs "bad foods") keeps the conversation collaborative.

The Deteriorating Patient

Some curveballs are more serious: the patient whose chronic condition is deteriorating. An elderly patient whose memory is noticeably worse. A heart failure patient with increasing breathlessness. A diabetic patient whose HbA1c has risen despite treatment.

These cases test your ability to escalate appropriately. The routine review plan is no longer suitable. You need to recognise the deterioration, reassess the management plan, and potentially involve secondary care.

The structure for a deteriorating patient consultation:

Name the change. "I can see from your recent results that your HbA1c has gone up from 52 to 68 since our last review. That tells me the current treatment isn't controlling your blood sugar as well as it was." Be direct about the deterioration without being alarmist.

Explore why. Has something changed in the patient's life (stress, bereavement, financial difficulties)? Have they stopped or changed their medication? Has their condition genuinely progressed? The cause of the deterioration determines the response.

Adjust the plan. This may mean adding or changing medication, referring to a specialist, arranging more frequent monitoring, or addressing a psychosocial factor. The key is that the plan changes in response to the new information. Continuing the same plan when the condition is deteriorating is the mistake the examiner is watching for.

End of Life Care: Pain Management is the most emotionally complex version of this case type. The patient's condition is deteriorating and the curveball is that the goals of care are shifting from active treatment to comfort. This requires you to have a conversation about what the patient wants for the remainder of their life, which crosses into the territory covered by our end of life care guide.

Common Mistakes in Chronic Disease Cases

Mistake 1: Sticking to the pre-planned review. The case notes suggest a routine review. You prepared for a routine review. The patient reveals the curveball. You continue with the routine review anyway because that is what you prepared for. This is the most common and most costly mistake. Adapt.

Mistake 2: Lecturing on lifestyle. Delivering a monologue about diet, exercise, and alcohol without asking the patient what they already know, what they are willing to change, or what barriers they face. This fails Relating to Others and produces a plan the patient will not follow.

Mistake 3: Insisting on guideline-adherent treatment. Guidelines are evidence-based recommendations, not mandates. If a patient declines a guideline-recommended treatment after an informed discussion, that is their right. Your job is to inform and advise, not to insist. Document the discussion and arrange follow-up.

Mistake 4: Ignoring the psychosocial context. Chronic disease does not exist in isolation. A deteriorating HbA1c in a patient who is also caring for a dying spouse has a different cause and a different management plan from the same HbA1c in a patient who is otherwise well. The LIIF framework (Life, Impact, Interest, Feelings) is particularly useful in chronic disease cases for uncovering the context that determines the plan.

Mistake 5: Trying to cover everything. A chronic disease review could cover medication, lifestyle, monitoring, screening, complications, referrals, self-management education, and more. In 12 minutes, you cannot cover everything. Prioritise the curveball and the most important clinical actions. Signpost the rest: "There are a few other things I'd normally cover in your annual review. Let's book a follow-up appointment where we can go through those."

Frequently Asked Questions

What is a chronic disease curveball in the SCA?

A curveball is an unexpected element in what appears to be a routine chronic disease review. The case notes suggest a standard medication review or follow-up, but during the consultation the patient reveals something that changes the clinical picture: a new symptom, a medication side effect, a concern about treatment, a deterioration, or a psychosocial factor that affects management. The RCGP uses curveballs to test whether you can adapt your plan when the situation changes.

How do I spot the curveball early?

During the reading time, look for clues in the case notes that suggest complexity: multiple medications (polypharmacy risk), recent blood results (may show a change), or a vague reason for attendance ('routine review' often hides the real reason). In the consultation itself, listen for cues in the first 3 minutes: the patient mentions something that does not fit the expected narrative. Follow that cue immediately rather than completing your pre-planned review structure.

What if I miss the curveball and only realise at minute 8?

Acknowledge it and adapt. 'You mentioned earlier that you've been feeling dizzy since starting the new medication. I think that's important and I'd like to come back to that.' It is better to acknowledge a missed cue late than to ignore it entirely. The examiner will note that you eventually identified and addressed the issue, which is partial credit rather than no credit.

How do I handle a patient who disagrees with the guideline-recommended treatment?

Shared decision-making is the framework. Present the evidence for the recommended treatment clearly and in plain language. Explore the patient's reasons for disagreement (often rooted in side effect concerns, media reports, or previous bad experiences). Offer alternatives where they exist. Document the discussion and the patient's informed decision. You do not need the patient to agree with you. You need to demonstrate that you informed them, listened to their perspective, and reached a plan together.

Are chronic disease cases easier or harder than acute cases?

They are different, not necessarily harder. Acute cases test rapid clinical decision-making and red flag identification. Chronic disease cases test shared decision-making, medication counselling, lifestyle advice, and adaptability when the curveball appears. Many trainees find chronic disease cases harder because they require longer, more nuanced conversations and there is often no single 'right answer' to aim for.

How to Explain Results and Diagnoses in the SCA · 9 min
SCA Safety Netting: How to Do It in Every Case Type · 9 min
SCA Time Management: How to Structure the 12-Minute Consultation · 10 min
What the SCA Actually Tests: A Guide to Story-Led Consulting · 12 min
SCA End of Life Care: How to Approach the Most Emotionally Challenging Cases · 10 min